Jim Cramer: Why CVS Health Stock is Soaring This Year
CNBC TelevisionSeptember 5, 20258 min6,127 views
19 connectionsΒ·26 entities in this videoβCVS Health's Remarkable Turnaround
- π CVS Health has been a rare bright spot in the struggling healthcare sector, with its stock up over 58% this year.
- π‘ This performance is attributed to CVS becoming the last major rival standing in retail pharmacy, with competitors like Walgreens and Rite Aid facing significant challenges.
Managed Care Business Recovery
- π The managed care division, Aetna, which was a drag last year due to low pricing and high medical costs, is showing a significant turnaround.
- β In the latest quarter, the healthcare benefits division saw nearly 12% revenue growth and operating income up almost 40% year-over-year.
- π CVS's medical benefits ratio improved, coming in lower than Wall Street expectations, despite elevated utilization rates.
Strength Across All Business Segments
- π The drugstore business, encompassing both front-of-store and pharmacy, delivered a $1.5 billion revenue beat, with operating income up 7.6%.
- π₯ The health services division, including the Caremark PBM and MinuteClinic, achieved 10.2% revenue growth.
- π― All three of CVS's core businesses (pharmacy, PBM, and managed care) exceeded expectations in the recent quarter.
Financial Performance and Outlook
- π° CVS raised its full-year forecast significantly, boosting revenue guidance by nearly $9 billion and earnings outlook by 25 cents.
- π Despite the substantial stock rally, CVS trades at only 11 times its new full-year earnings forecast, considered very cheap.
- πΈ The company offers a generous annual dividend of $2.66, resulting in a 3.7% yield.
Leadership and Investor Confidence
- π CEO David Joiner, in his first 10 months, has been praised for quickly addressing problems and driving the company's transformation.
- π Analysts at UBS upgraded CVS to a 'buy,' citing strong execution and positive signs in the healthcare benefits segment.
- β Cramer believes the turnaround is well underway, and with its cheap valuation and strong dividend, CVS has more room to run.
Knowledge graph26 entities Β· 19 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover Β· drag to explore
26 entities
Chapters5 moments
Key Moments
Transcript33 segments
Full Transcript
Topics15 themes
Whatβs Discussed
CVS HealthJim CramerMad MoneyHealthcare SectorRetail PharmacyWalgreensRite AidAetnaManaged CarePharmacy Benefit Manager (PBM)CaremarkMedical UtilizationMedicare AdvantageStock PerformanceDividend Yield
Smart Objects26 Β· 19 links
CompaniesΒ· 10
ConceptsΒ· 11
ProductsΒ· 2
PeopleΒ· 3